The Mexico pharmacy retail market size reached USD 28.98 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 48.10 Billion by 2033, exhibiting a growth rate (CAGR) of 5.79% during 2025-2033. The aging population, rising chronic‐disease burden driving consistent medication demand, the aggressive expansion of national chain networks complemented by omnichannel innovations, e‐pharmacy adoption and home‐delivery via marketplaces, and supportive government healthcare spending are some of the key factors catalyzing the market growth.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 28.98 Billion |
Market Forecast in 2033 | USD 48.10 Billion |
Market Growth Rate 2025-2033 | 5.79% |
Expansion of Omnichannel and E-Pharmacy Platforms
Mexico’s pharmacy retail sector is rapidly evolving through digital transformation, marked by the widespread adoption of omnichannel strategies and e-pharmacy services. Traditional pharmacy chains are increasingly integrating in-store offerings with digital platforms to boost convenience, accessibility, and customer retention. Since the COVID-19 pandemic, e-commerce has reshaped consumer habits, with online medicine sales in Mexico rising as a share of total retail pharmacy revenue. Major players such as Farmacias del Ahorro, Farmacias Similares, and e-marketplaces like Mercado Libre have expanded to include services such as teleconsultations, prescription fulfillment, and home delivery. This shift is largely fueled by Mexico’s rising internet penetration, which surpassed 75% of the population in 2023, according to the Federal Telecommunications Institute (IFT). Moreover, increasing smartphone adoption among older adults, key users of prescription drugs, has made digital health services more accessible. E-pharmacy platforms also leverage data to personalize user experiences, offering features like loyalty programs, automated refills, and app-based reminders that enhance adherence and drive long-term revenue growth.
Increased Demand Due to Chronic Diseases and an Aging Population
The rising incidences of chronic non-communicable diseases (NCDs), such as diabetes, hypertension, and obesity, are also significantly boosting pharmaceutical demand across Mexico. As per Mexico’s National Health and Nutrition Survey (ENSANUT), over 10 million people are living with diabetes and nearly 20 million with hypertension; these figures expected to grow through 2025, prompting frequent and sustained pharmacy visits. Simultaneously, Mexico’s aging population is contributing to this trend, with citizens aged 60 and above projected to reach 20 million by 2030, up from approximately 15 million in 2023. This demographic increasingly depends on ongoing medication regimens, wellness supplements, and health monitoring. In response, retail pharmacies are expanding their offerings to include chronic care medications, point-of-care diagnostics like glucose and blood pressure testing, and pharmaceutical consultations. Government initiatives such as Seguro Popular and broader IMSS coverage are also improving medication access for underserved, low-income groups. These factors are positioning pharmacies as vital community health hubs, delivering not only medications but also education, disease screening, and long-term care, ultimately strengthening their role and fueling sustained market growth.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region/country level for 2025-2033. Our report has categorized the market based on market structure, product type, therapeutic area, drug type, and pharmacy location.
Market Structure Insights:
The report has provided a detailed breakup and analysis of the market based on the market structure. This includes unorganized and organized.
Product Type Insights:
A detailed breakup and analysis of the market based on the product type have also been provided in the report. This includes over-the-counter products, prescribed drugs, non-pharmaceutical products, and medical equipment.
Therapeutic Area Insights:
The report has provided a detailed breakup and analysis of the market based on the therapeutic area. This includes cardiovascular, pain relief/analgesics, vitamins/minerals/nutrients, anti-infective, anti-diabetic, and others.
Drug Type Insights:
A detailed breakup and analysis of the market based on the drug type have also been provided in the report. This includes generic and patented.
Pharmacy Location Insights:
The report has provided a detailed breakup and analysis of the market based on the pharmacy location. This includes street/mall based and hospital based.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Northern Mexico, Central Mexico, Southern Mexico, and others.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Market Structures Covered | Unorganized, Organized |
Product Types Covered | Over-the-Counter Products, Prescribed Drugs, Non-Pharmaceutical Products, Medical Equipment |
Therapeutic Areas Covered | Cardiovascular, Pain Relief/Analgesics, Vitamins/Minerals/Nutrients, Anti-Infective, Anti-Diabetic, Others |
Drug Types Covered | Generic, Patented |
Pharmacy Locations Covered | Street/Mall Based, Hospital Based |
Regions Covered | Northern Mexico, Central Mexico, Southern Mexico, Others |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: